ImportRefusal LogoImportRefusal

CHRONIC LYME TREATMENTS

⚠️ Moderate Risk

FEI: 3016619648 • Squamish, BC • CANADA

FEI

FEI Number

3016619648

📍

Location

Squamish, BC

🇨🇦

Country

CANADA
🏢

Address

#113 - 38003 2nd Avenue, , Squamish, BC, Canada

Moderate Risk

FDA Import Risk Assessment

45.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
1
Unique Violations
4/7/2020
Latest Refusal
4/7/2020
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
4/7/2020
54FYL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/7/2020
54FYL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/7/2020
54FYL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is CHRONIC LYME TREATMENTS's FDA import refusal history?

CHRONIC LYME TREATMENTS (FEI: 3016619648) has 3 FDA import refusal record(s) in our database, spanning from 4/7/2020 to 4/7/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CHRONIC LYME TREATMENTS's FEI number is 3016619648.

What types of violations has CHRONIC LYME TREATMENTS received?

CHRONIC LYME TREATMENTS has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CHRONIC LYME TREATMENTS come from?

All FDA import refusal data for CHRONIC LYME TREATMENTS is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.